Cardlytics, Inc. - Gabelli Research Analyst Matthew Trusz

April 26, 2018 - 1:54 minutes

Matthew Trusz is a research analyst with Gabelli & Company covering Industrials - Building Products.

The Research Analyst in this public appearance certifies that the views expressed in this video accurately reflect his/her personal views about the subject companies and their securities. The Research Analyst has not been, is not and will not be receiving direct or indirect compensation for expressing the specific recommendation or view in this video.

Gabelli & Company is the marketing name for the registered broker dealer G.research, LLC, which was formerly known as G.research, Inc. Gabelli & Company ("we" or "us") attempts to provide timely, value-added insights into companies or industry dynamics for institutional investors. Our research reports generally contain a recommendation of "buy," "hold," "sell" or "non-rated." We do not undertake to "upgrade" or "downgrade" ratings after publishing a report. We currently have reports on 382 companies, of which 59%, 30%, 1% and 10% have a recommendation of buy, hold, sell or non-rated, respectively. The percentage of companies so rated for which we provided investment banking services within the past 12 months is 0%, 0%, 0% and less than 1%.

Ratings - Analysts' ratings are largely (but not always) determined by our "private market value," or PMV methodology. Our basic goal is to understand in absolute terms what a rational, strategic buyer would pay for an asset in an open, arms-length transaction. At the same time, analysts also look for underlying catalysts that could encourage those private market values to surface.

A Buy rated stock is one that in our view is trading at a meaningful discount to our estimated PMV. We could expect a more modest private market value to increase at an accelerated pace, the discount of the public stock price to PMV to narrow through the emergence of a catalyst, or some combination of the two to occur.

A Hold is a stock that may be trading at or near our estimated private market value. We may not anticipate a large increase in the PMV, or see some other factors at work.

A Sell is a stock that may be trading at or above our estimated PMV. There may be little upside to the value, or limited opportunity to realize the value. Economic or sector risk could also be increasing.

We prepared this video as a matter of general information. We do not intend for the video to be a complete description of any security or company and it is not an offer or solicitation to buy or sell any security. All facts and statistics are from sources we believe to be reliable, but we do not guarantee their accuracy. We do not undertake to advise you of changes in our opinion or information.

Unless otherwise noted, all stock prices reflect the closing price on the business day immediately prior to the date of this video. We do not use "price targets" predicting future stock performance. We do refer to "private market value" or PMV, which is the price that we believe an informed buyer would pay to acquire 100% of a company. There is no assurance that there are any willing buyers of a company at this price and we do not intend to suggest that any acquisition is likely. Additional information is available on request.

Because the portfolio managers at our affiliates make individual investment decisions with respect to the client accounts they manage, these accounts may have transactions inconsistent with the recommendations in this report. These portfolio managers may know the substance of our video prior to their publication as a result of joint participation in research meetings or otherwise.

No part of the research analyst compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this research video. In addition, the undersigned lead analyst(s) has not received any compensation from the subject company in the previous 12 months.

As of March 31, 2018 our affiliates beneficially own on behalf of their investment advisory clients or otherwise less than 1% of Cardlytics and Wells Fargo. The analyst, who prepared this video, or members of his household own 0 shares of Cardlytics and Wells Fargo.

Stocks are subject to market, economic and business risks that cause their prices to fluctuate. When you sell shares, they may be worth less than what you paid for them.

Investors should carefully consider the investment objectives, risks, charges and expenses of the Fund before investing. The prospectus and summary prospectus, which contains more complete information about this and other matters, should be read carefully before investing.